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THE “GRAY-COLORED TUMOR” OF alpha-methyl-dopa treatment and not 
proven to have pheochromocytoma have 
been the basis for “normal” values. At least 
two of these patients with values considered 
“normal” have undergone celiotomy and an 
abdominal pheochromocytoma was not 
found. Multiple follow-up studies have in- 
dicated the others not to have the tumor. 
THE ADRENAL medulla has fascinated 
physicians for 80 years. The diagnosis in 
the past has been hazardous and error 
prone. The variety of diagnostic measures 
currently recommended suggest there has 
been little consensus on the best approach. 
The purpose of this presentation is to give 
our convictions on definitive diagnosis 
based on 6 years’ experience in a highly 
specialized laboratory in a large medical 
center. By definitive diagnosis is meant 
sufficient confidence in the results to oper- 
ate on the patient without further diag- 
nostic investigation. 
MATERIALS 
From 1966 to 1972, urinary epinephrine 
and norepinephrine have been determined 
preoperatively on 22 patients subsequently 
demonstrated to have histologically verified 
pheochromocytoma. Sixteen proven cases 
have had preoperative metanephrine and 
normetanephrine urinary studies. Multiple 
preoperative urine studies on most patients 
give a total of 63 preoperative urine 
samples for epinephrine or norepinephrine 
and 29 for metanephrine and normeta- 
nephrine. Hypertensive patients not on 
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METHODS 
When a pheochromocytoma is to be ruled 
out, two 12-hr overnight urine specimens 
are collected in a tinted bottle containing 
10 ml 6 N HCl acid to keep the pH less 
than 3.0. Free catecholamines (epinephrine 
and norepinephrine) and metanephrine 
metabolites (metanephrine and normeta- 
nephrine) are measured using fluorometric 
trihydroxyindole methods of biochemical 
determination [4, 121. Alpha-methyl-dopa 
treatment of hypertension must be ruled out 
in every case because it has been found to 
falsely elevate both free catecholamine [6] 
and metanephrine metabolite values to diag- 
nostic range for at least 2 weeks. No diet 
restrictions are imposed. Outpatient collec- 
tions are readily made. Specimens sent by 
public conveyance have been acceptable as 
long as the urine pH remains below 3 [5]. 
When the definitive diagnosis has been 
made, attempts at localization are often 
done (chest X-ray, IVP, venogram, caval 
catheterization, arteriogram, and 1311 
cholesterol scan) but have not been con- 
sidered essential in uncomplicated cases. 
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(n = 100) (n = 63) 
28.9’ f 29.0b (P < 0.001) 1250 + 2456 
7.6 * 7.4 (P < 0.001) 238 + 408 
Normal Pheochromocytoma 
(n = 37) (n = 29) 
44.2 rt 38.9 (P < 0.001) 1127 f 842 
32.9 + 16.4 (P < 0.001) 1305 * 1708 
a All urinary values in micrograms per 24 hr. 
b + 1 Standard deviation. 
Table 2. Basis of Criteria for Definitive Diagnosis 
Urinary norepinephrine and epinephrine 
Strongly positive 90% ( > 5 SD) 
Falsely positive 2 y0 
Urinary Normetanephrine and Metanephrine 
Strongly positive 100% ( > 5 SD) 
Falsely positive 5 y0 
.- 
RESULTS 
Table 1 shows the mean urinary levels 
in nonpheochromocytoma hypertensives to 
be norepinephrine 28.9 4 29.0” pg/24 hr, 
epinephrine 7.6 +- 7.4 pg/24 hr, normeta- 
nephrine 44.2 + 38.9 pg/24 hr, metaneph- 
rine 32.9 k 16.4 pg/24 hr. These are com- 
pared to the mean values found in proven 
pheochromocytoma patients, norepinephrine 
1250 k 2456 pg/24 hr, epinephrine 238 I 
408 pg/24 hr, normetanephrine 1127 +- 842 
pg/24 hr, and metanephrine 1305 -+ 1708 
,ug/24 hr. All four group comparisons with 
Student’s t test show P < 0.001. High 
normal limits for 95% confidence could be 
considered to be the mean plus 2 SD. 
Anything above this we consider suspicious 
but the diagnostic range has occurred at 5 
SD in excess of the normal mean. 
Using these criteria, urinary norepi- 
nephrine and epinephrine were diagnostic 
in 90% of all overnight urine collections in 
proven cases with 2% falsely positive in 
nonpheochromocytoma hypertensives. All 
29 urine samples tested for metanephrine 
metabolites were diagnostic with approxi- 
* +l Standard Deviation., 
mately 5% falsely positive (Table 2). No 
patient without pheochromocytoma had 
false positives in both free catecholamines 
and metanephrine metabolite determina- 
tions. No patient with a pheochromocytoma 
had a falsely negative urine for metane- 
phrine metabolites. Crisis samples have not 
been helpful and their interpretation is 
doubtful. We do not rely on them for 
diagnosis. 
DISCUSSION 
Multiple biochemical screening and other 
diagnostic tests for pheochromocytoma 
have been suggested that are relatively in- 
expensive and uncomplicated. These in- 
clude the calorimetric technique for 
Vanillylmandelic acid (VMA) of Gitlow et 
al. [8, 91 and total metanephrine excretion 
by electrophoretic chromatography [ 151. 
These are discussed in detail by Gitlow et 
al. in later publications [7, 141 with excel- 
lent results. However, most of the less 
specific techniques for VMA currently in 
use in many clinical laboratories offer only 
confusing diagnostic aid [l] with up to 
30% falsely positive and negative results 
[lo]. Crout [2] suggested that VMA tests 
are less accurate than free catecholamines 
and metanephrine metabolite excretion. 
Since savings in time and expense in our 
own hospital were negated by the large 
number of VMA tests that had to be re- 
done, we have continued to recommend 
only free catecholamine and metanephrine 
metabolite urinary studies for pheochromo- 
cytoma evaluation. We agree with 
PREIEK ASI) HAHHIHON: I)IAGNOSIS OF PHEOC’HltO.\lOC1’l~O~~A 1 i!) 
Pertsemlidis et al. [14] that more than one 
mcasurcment of several urinary products is 
sufficient for diagnosis and disagree with 
Mahoney et al. [ 131 that multiple methods 
be utilized as well as multiple determina- 
tions with each technique. The interfering 
medication, alpha-methyl-dopa, must be 
ruled out, as well as severe strcssea such as 
large thermal burns. In our laboratory we 
have found that al~~l~a-metl~yl-clo1,:1 cannot 
only elevate the catecholamines but the 
metanephrine mctabolites as well to diag- 
nostic range. 
The overnight 12-hr resting collection 
has been very satisfactory. Unusual stress 
and activity is avoided and the convenience 
for the patient results in more accurate 
collection. 
Since Crout’s suggestion in 1961 [3] that 
metanephrine metabolitcs be measured, it 
has been shown to be of excellent diagnostic 
support [ 2, 7, 10, 141. Our results have been 
most encouraging. No patient with a pheo- 
chromocytoma has had a single negative 
urine for both metanephrine or normcta- 
nephrine. 
Provocative and suppressive pharmaco- 
logic studies have no place in modern pheo- 
chromocytoma diagnosis. The definite 
dangers and gross inaccuracies are docu- 
mented in almost every report on this 
subject. 
Tumor localization after the diagnosis 
has been made is often done to help cstab- 
lish whether or not there is more than one 
lesion. Efforts at localization in this institu- 
tion have been previously published 1111. 
SUMMARY 
Based on urinary studies of patients with 
pheochromocytoma as compared to hyper- 
tcnsives considered to be without this 
tumor, rigorous biochemical criteria for 
diagnosis are proposed. Free catecholamines 
in 90% and mctanephrine metabolites in 
100% of the pheochromocytoma patients’ 
urine samples exceeded the normal (hyper- 
tensive) values by more than 5 SD. No 
patient without pheochromocytoma has 
falsely positive values in both free cate- 
cholaminc and metanephrine mctabolite de- 
terminations. So patient with a pheo- 
chromocytoma had a urine sample negative 
for mctancphrinc~ metabolitcs. The com- 
bination of these studies has given excellent 
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